Abstract
The extent of heterogeneity in antipsychotic treatment response for over extended period is unclear. This study aimed to quantify treatment response trajectories and their characteristics up to 2 years in recent-onset psychosis. Participants were from a double-blind randomized controlled trial of recent-episode psychosis (N = 263). Recurrent Positive and Negative Syndrome Scale (PANSS) administrations were used to index treatment response trajectories for up to 2 years. Trajectories were calculated with mixed-mode latent class regression modeling from which groups were derived. Group differences were examined on sex, age of first admission, duration of untreated psychosis, premorbid functioning, diagnoses of substance abuse and schizophrenia, and cognitive functioning. Five trajectories based on PANSS total scores were identified at 2 years. In the trajectory group (23.1%) with the most improvement, approximately 62% met the PANSS 30% change criteria. Logistic regression modeling indicated that membership in the trajectory with the most improvement was significantly (P < 0.05) predicted by absence of a diagnosis of schizophrenia, better premorbid functioning, and higher cognitive scores. Membership in the trajectory with the le...Continue Reading
References
Jan 1, 1982·Schizophrenia Bulletin·H E Cannon-SpoorR J Wyatt
Apr 1, 1997·The American Journal of Psychiatry·H Y MeltzerP A Thompson
Jun 27, 2000·Schizophrenia Research·D O PerkinsJ A Lieberman
Apr 25, 2001·Archives of General Psychiatry·D S Nagin, R E Tremblay
Nov 27, 2002·The American Journal of Psychiatry·Jonathan RabinowitzMichael Davidson
Jun 11, 2003·Archives of General Psychiatry·Andre AlemanJean-Paul Selten
Aug 6, 2003·The American Journal of Psychiatry·Jeffrey A LiebermanUNKNOWN HGDH Study Group
Apr 6, 2004·Schizophrenia Research·Alan I GreenUNKNOWN HGDH Research Group
Sep 6, 2005·Biological Psychiatry·Richard S E KeefeUNKNOWN HGDH Research Group
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Oct 4, 2005·The American Journal of Psychiatry·Diana O PerkinsJeffrey A Lieberman
Oct 4, 2005·The American Journal of Psychiatry·Philip D HarveyMichael Davidson
Jul 4, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Jonathan RabinowitzMichael Davidson
Aug 29, 2007·Psychological Bulletin·Abraham Reichenberg, Philip D Harvey
Jan 24, 2008·Schizophrenia Bulletin·Jonathan Rabinowitz, Ori Davidov
Citations
Mar 7, 2013·Psychological Medicine·J M Pelayo-TeránB Crespo-Facorro
Nov 26, 2013·Journal of Child and Adolescent Psychopharmacology·Marie Stentebjerg-OlesenChristoph U Correll
Jan 1, 2014·Psychiatry Research·Markus JägerReinhold Kilian
Nov 1, 2013·European Archives of Psychiatry and Clinical Neuroscience·Elsa GilbertMichel Maziade
Nov 29, 2013·BMC Psychiatry·Lei ChenHaya Ascher-Svanum
Feb 10, 2012·Schizophrenia Research·Stephen Z LevineHaya Ascher-Svanum
Oct 3, 2012·International Journal of Offender Therapy and Comparative Criminology·Katherine L MontgomeryMatthew O Howard
Nov 3, 2017·PloS One·Edimansyah AbdinMythily Subramaniam
Apr 23, 2013·Acta Psychiatrica Scandinavica·C NordonB Falissard
Jul 23, 2020·Translational Psychiatry·Tesfa Dejenie HabtewoldBehrooz Z Alizadeh
Jun 27, 2013·Depression and Anxiety·Jutta M JoeschPeter P Roy-Byrne
Jan 1, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jimmy LeeGary Remington
Oct 23, 2020·BJPsych Open·Minhan DaiUNKNOWN Chinese Antipsychotics Pharmacogenomics Consortium
Mar 30, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gemma PratAna Adan
May 22, 2020·Psychiatry Research·Lone BaandrupBirte Y Glenthøj
Sep 28, 2021·Statistical Methods in Medical Research·Chi ChangUNKNOWN Pooled Resource Open-Access ALS Clinical Trials Consortium